No signal was created. Models could not agree on a directional bias.
All three models highlight a compelling mean-reversion setup driven by extreme oversold conditions (RSI ~22.9) and proximity to a high-volume support node near ₹1,359/mid-15 levels. Fundamental support is bolstered by raised FY26 revenue guidance and strategic AI initiatives, including the Siemens partnership and 'The Missing Link' acquisition, which two models suggest improve sentiment skew. Analysts from Elara and Motilal Oswal provide significant valuation tailwinds with price targets up to ₹1,850 (+35% upside), while the low beta (0.26) and high ROE (32.7%) offer defensive quality in a calm market regime.
All three models flag severe technical deterioration, specifically citing a 'Death Cross' (50 SMA below 200 SMA) and a recent 9.78% EPS miss that has damaged guidance credibility. Two models emphasize the 'AI deflation' risk, where generative AI may cannibalize legacy IT billings, evidenced by a 3% price drop following the AI roadmap event. Unique concerns include institutional distribution signaled by a 'Bearish Engulfing' candle on high volume, anemic buying conviction (69% of average volume), and potential downside toward ₹1,281.50 as the stock trades below its value area low.
Bull and bear cases balanced — no clear edge
INFY shows compelling technical reversal potential with RSI(22.91) deeply oversold near strong historical support at ₹1281.50 while trading 11.4% below resistance. The recent AI partnership expansion with Siemens and raised FY26 revenue guidance (+3.5%) creates fundamental momentum. Market regime favors calm trending environments (76% confidence) supporting mean reversion setups.
INFY shows sustained technical weakness below key SMAs with bearish momentum, evidenced by 3% post-AI event drop despite $400B roadmap as markets price in AI's deflationary impact on legacy revenue. Recent 9.78% EPS miss and below-average volume reflect weak institutional conviction amid semiconductor export control risks.
INFY is extremely oversold on the daily timeframe (RSI ~22.9) while trading only ~5–6% above a clear support zone near the 52-week low, creating an attractive mean-reversion setup where downside is more definable than upside. Volume profile shows current price sitting on/near a high-volume node around the mid-15 area (HVN) , which often acts as a “base” that can fuel a swing back toward the next major resistance (~ $17) if selling pressure fades. On the catalyst side, management’s recent AI-focused messaging (Investor AI Day) and the raised FY26 revenue guidance reported in recent coverage improve sentiment skew, and the broader market regime is calm/trend-friendly (VIX complacent/contango) , which historically supports grind-up reversals from washed-out conditions.
Price is below the key moving averages (SMA20 < SMA50 and price ~3% under them) , with RSI still falling—suggesting downside momentum hasn’t fully exhausted despite being oversold. Volume is running ~0.69× average, implying weak dip-buying demand, and the volume profile shows the broader POC far overhead (~1672) , consistent with prior high-volume “fair value” much higher and current trade being in a lower acceptance zone; rallies into ~1380–1400 are likely to be sold. With support only ~5–6% beneath current price (~1281/1296 lower band) , a breakdown risks a quick acceleration lower as stops trigger under the 52-week low area.
Bull and bear cases balanced — no clear edge
INFY presents a compelling mean-reversion opportunity at deeply oversold levels with RSI at 22.91 (extreme oversold) , trading just 5.6% above 52-week lows and near a high-volume support node at ₹1, 359. The technical setup is reinforced by strong fundamental quality: 32.7% ROE, healthy 16.2% profit margins, and low beta (0.26) providing defensive characteristics in any volatility. Analyst sentiment is overwhelmingly bullish with Elara Capital targeting ₹1, 680 (+21% upside) and Motilal Oswal at ₹1, 850 (+35%) , driven by strategic AI initiatives and recent M&A (The Missing Link acquisition strengthens cybersecurity capabilities) . The calm market regime (76% confidence) with VIX complacent favors trend-following strategies, and INFY's NSE listing shows INLINE regional performance, eliminating geographic headwinds. With no earnings catalyst until April 2026, the stock has a clean 6-8 week runway to recover toward resistance at ₹1, 528, supported by FY25 revenue growth of 4.2% and robust ₹19.28B revenue base.
INFY suffered a brutal -9.78% earnings miss in January 2026 (₹16.14 vs ₹17.89 estimate), signaling deteriorating execution and guidance credibility. The stock has plunged -26% from 52-week highs and shows technical breakdown with SMA20 < SMA50 (bearish crossover), falling RSI momentum, and price trading 3.2% below both key moving averages. Volume is anemic at only 69% of average, indicating capitulation and lack of buying conviction. The value area low at ₹1337.31 is breached, with next major support at ₹1281.5 only 5.6% lower—minimal downside cushion before further collapse. IT services face structural headwinds from AI disruption threatening traditional outsourcing models, while the 3-month return of -7.72% confirms sustained selling pressure.
INFY has suffered a technical capitulation, breaking below the 200-day SMA and confirming a 'Death Cross' (50 SMA crossing below 200 SMA) , which historically signals prolonged downside. Fundamentally, the market is pricing in 'AI deflation' risk—the fear that Generative AI will cannibalize legacy IT service billings—causing INFY to de-rate despite guidance hikes. The recent 'Bearish Engulfing' candle on high volume indicates institutional distribution is accelerating.
INFY is presenting a classic mean-reversion opportunity, currently trading at major structural support ($14.19 52-week low) with RSI deeply oversold (approx. 33). The stock is significantly extended below its 20-day SMA, setting up a 'snap-back' rally as sellers exhaust. With NVIDIA earnings approaching, an AI-sector tailwind could catalyze a rotation back into undervalued IT services plays, targeting a reversion to the mean near $16.